RLX Technology Inc. American Depositary Shares (RLX)

2.0300
-0.0700 (-3.33%)
NYSE· Last Trade: May 20th, 2:42 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close2.100
Open2.220
Bid2.030
Ask2.040
Day's Range2.020 - 2.220
52 Week Range1.940 - 2.840
Volume4,875,986
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & Yield0.0100 (0.49%)
1 Month Average Volume1,767,089

Chart

About RLX Technology Inc. American Depositary Shares (RLX)

Rlx Technology Inc is a leading company in the production and distribution of innovative vaping products and smokeless electronic devices, catering primarily to the Chinese market. The company focuses on creating high-quality, user-friendly vaping solutions designed to enhance the consumer experience while promoting a smoke-free lifestyle. With a strong commitment to research and development, Rlx Technology aims to offer a diverse range of products that meet evolving consumer preferences and regulatory standards, positioning itself as a key player in the growing nicotine alternatives market. Read More

News & Press Releases

RLX (RLX) Q1 2026 Earnings Call Transcriptfool.com
RLX (RLX) Q1 2026 Earnings Call Transcript
Via The Motley Fool · May 20, 2026
RLX (RLX) Q4 2025 Earnings Call Transcriptfool.com
RLX (RLX) Q4 2025 Earnings Call Transcript
Via The Motley Fool · May 20, 2026
RLX Technology Q1 Earnings Call Highlightsmarketbeat.com
RLX Technology (NYSE:RLX) reported a sharp increase in first-quarter 2026 revenue, driven by international expansion, contributions from a European investment and continued stability in mainland China, executives said on the company’s earnings call. Chief Executive Officer Kate Wang said the compan
Via MarketBeat · May 20, 2026
RLX Technology (NYSE:RLX) Soars 3.8% Pre-Market on Massive Q1 2026 Revenue Beat, Topping Estimates by 34%chartmill.com
Via Chartmill · May 20, 2026
A China Tech Fund Opens a Biotech Position — Here's What That Actually Signalsfool.com
Legend Biotech develops cell therapies for cancer, with a pipeline spanning hematologic malignancies and solid tumors.
Via The Motley Fool · May 17, 2026
With YMM Down 29%, First Beijing Bought 13 Million More Sharesfool.com
Full Truck Alliance is a top digital freight platform in China, connecting shippers and truckers through tech-enabled logistics services.
Via The Motley Fool · May 17, 2026
Why a Nearly $500 Million Bet on New Oriental Signals Conviction Amid a 13% Slidefool.com
A sharply concentrated fund leaned further into New Oriental even as sentiment cooled.
Via The Motley Fool · January 1, 2026
Why One Fund Made a $12.5 Million Bet on KE Holdings Despite a 12% One-Year Stock Slidefool.com
A contrarian allocation into China’s largest housing platform highlights where disciplined capital is looking for durability, cash flow, and optionality in an out-of-favor market.
Via The Motley Fool · December 28, 2025
Billionaire Family Office Dumps All of Its UroGen Stock Amid 100% Rallyfool.com
A full exit after a monster rally says less about the company’s science and more about how disciplined funds lock in wins when portfolio math starts to matter.
Via The Motley Fool · December 26, 2025
What a Billionaire Family Office's $16.6 Million Exit From TIC Solutions Signals for Long-Term Investorsfool.com
A patient, partnership-driven family office didn’t wait for fundamentals to break before walking away, and that timing may matter more than the sale itself.
Via The Motley Fool · December 26, 2025
Globalization Strategy Fires Up Vaping leader RLXbenzinga.com
Via Benzinga · November 20, 2025
Legence, Cidara Therapeutics, Avadel Pharmaceuticals, Omeros And Other Big Stocks Moving Higher On Fridaybenzinga.com
Via Benzinga · November 14, 2025
RLX Technology (RLX) Q3 2025 Earnings Transcriptfool.com
RLX Technology (RLX) Q3 2025 Earnings Transcript
Via The Motley Fool · November 14, 2025
Why RLX Technology Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · November 14, 2025
Earnings Scheduled For November 14, 2025benzinga.com
Via Benzinga · November 14, 2025
Rapport Therapeutics, Planet Labs, QuantumScape, EchoStar And Other Big Stocks Moving Higher On Mondaybenzinga.com
Via Benzinga · September 8, 2025
Top 2 Defensive Stocks That May Keep You Up At Night This Quarterbenzinga.com
Via Benzinga · September 2, 2025
RLX Technology Inc. (NYSE:RLX) Reports Mixed Q2 2025 Results with Revenue Beat and EPS Misschartmill.com
RLX Technology Q2 2025 results: Revenue of $881.9M beats estimates, but EPS of $0.144 falls short, indicating mixed performance.
Via Chartmill · August 22, 2025
Earnings Scheduled For August 22, 2025benzinga.com
Via Benzinga · August 22, 2025
RLX TECHNOLOGY INC-ADR (NYSE:RLX) Fits Minervini’s Trend Template with Strong Momentum and Growth Potentialchartmill.com
RLX Technology (NYSE:RLX) fits Mark Minervini’s Trend Template with strong technicals, high relative strength, and accelerating revenue & earnings growth, making it a high-growth momentum candidate.
Via Chartmill · August 1, 2025
Earnings Scheduled For May 16, 2025benzinga.com
Via Benzinga · May 16, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RLX Technology Inc. - RLX
NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  RLX Technology Inc. (“RLX” or the “Company”) (NYSE: RLX).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · May 9, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RLX Technology Inc. - RLX
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  RLX Technology Inc. (“RLX” or the “Company”) (NYSE: RLX).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · May 5, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of RLX Technology Inc. – RLX
NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of RLX Technology Inc. (“RLX” or the “Company”) (NYSE: RLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · April 29, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RLX Technology Inc. - RLX
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  RLX Technology Inc. (“RLX” or the “Company”) (NYSE: RLX).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · April 25, 2025